Market

Precision medicine and biologics drive a paradigm shift in COPD treatment across the US, EU5, and Japan, but pricing pressures and…

GlobalData data shows a 46.9% drop in deal value and a 21.4% decline in venture capital investments year-on-year

Pharma funding reaches $79M in march 2025, driven by late-stage investments

AGA’s new UC guideline to accelerate adoption of advanced therapies and reshape payer strategies, says GlobalData

The scope of this initiative is being extended to more provinces of Argentina and additional therapeutic segments, including…

Unveils plans to expand clinical trials in India for its proprietary drug called NEO100, an ultra-purified perillyl alcohol with…

This new fund is part of a series of supportive steps Japan took over the past few years to enhance its pharmaceutical sector…

The revival of CNS drug development is being fueled by advancements in neuroimmunology and neurodegeneration, moving beyond…

GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…

Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the…

According to GlobalData’s Drugs Database, blood cancers account for over half of all CAR-Ts in the active pipeline* and make up…

Phase 3 SURPASS programme demonstrated that Mounjaro, whether used alone or with other diabetes medications, reduced A1C by up to…

GlobalData’s report reveals that the endometriosis market size across the seven major markets is expected to achieve a compound…

With the loss of exclusivity, Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability

It compares to the active ingredient in MiraLAX Powder for Solution, 17 grams of Bayer HealthCare

Report states that India’s CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on…

As per data provided by Tracxn, the decline in investment activity makes February 2025 one of the lowest-funded months in the past…

Zydus has reduced the cost of Letermovir by 91 per cent of the innovator price. ANVIMO will be available in dosages of 240 mg and…

The global Sugammadex market, valued at approximately 1.53 billion in 2023, is projected to grow at a CAGR of 8.5 per cent,…

Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA